David A. Phoenix, Frederick Harris, Sarah R. Dennison
Researchers from Europe, Asia, and the United States address a broad spectrum of existing and new antimicrobial drugs and therapies by integrating information from engineering, pharmacology, molecular medicine, and microbiology.
From small-molecule antibiotics to antimicrobial peptides and their tailored mimetics, metallic nanoparticles to photo- and sonosensitizers, enzymes to nucleic acid therapies, and phage therapy are all covered in this comprehensive assessment of novel antimicrobial agents and strategies (PDF). In every instance, the various therapeutic options are evaluated with regard to their underlying mechanisms, the likelihood of inducing resistance, and their efficacy in the context of the provision of healthcare on a worldwide scale.
unrivaled expertise for researchers and clinicians working in fundamental research, pharmacological development, and clinical practice.
“This would have been a wonderful addition to help put some of these new approaches into context,” said the researcher. “[T]his would have been very beneficial.” — ChemMedChem; 1 September 2015
NOTE: The product only comes with the PDF version of the ebook, which is titled Novel Antimicrobial Agents and Strategies. There are no access codes contained within.